ArticleVeterinary world2025
Development and evaluation of soy lecithin-derived nanoliposomes as a plant-based alternative to egg-yolk extender for Ongole-grade bull semen cryopreservation.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Quorum Sensing Modulators as Antibiotic Alternatives in Animal Production: From Bacterial Signaling to Gut Health and Performance.Veterinary sciences · 2026Review
- Enhancing cryopreservation performance in semen quality of Bali bulls (Journal of advanced veterinary and animal research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Conventional egg-yolk and milk-based extenders are widely used for semen cryopreservation but pose biosafety concerns and compositional variability that compromise standardization. Liposome technology offers a biosecure, uniform alternative. This study aimed to develop soy lecithin-derived nanoliposomes (NLs) using an ultrasonic-based process and to evaluate their efficacy as a Tris-based extender for Ongole-grade bull semen cryopreservation. Materials and Methods: Soy lecithin NLs were prepared through probe ultrasonication (15-45 min) and ultracentrifugation, followed by physicochemical characterization using particle size analysis, scanning electron microscopy (SEM), and high-resolution transmission electron microscopy. Tris-NL (TNL) extenders were formulated at concentrations of 5-25 mg/mL and compared with a Tris-egg-yolk (TEY, 20%) control. Fresh semen from five Ongole-grade bulls was evaluated for motility, viability, and morphology before and after freezing. Kinematic parameters were assessed through computer-assisted semen analysis, plasma membrane integrity by hypoosmotic swelling test, acrosome integrity using fluorescein isothiocyanate-conjugated peanut agglutinin/propidium iodide staining, and DNA fragmentation by Halomax-sperm chromatin dispersion assay. Results: Optimized sonication (45 min) produced stable NLs (mean diameter 76 nm, zeta potential -43.2 mV) with uniform spherical morphology. Among the tested formulations, TNL 5-10 mg/mL showed significantly higher (p < 0.05) post-equilibration motility (up to 98%), progressive motility, and kinematic parameters (velocity curved line, velocity average path, and velocity straight line) than TEY. Post-thaw evaluations demonstrated improved sperm viability (≈66%), reduced abnormalities (<7%), enhanced plasma-membrane and acrosomal integrity, and lower DNA fragmentation (~1.2%) in the 5-10 mg/mL groups. SEM confirmed smoother sperm surfaces with minimal cryo-damage compared with TEY. Conclusion: Soy lecithin-derived NLs at 5-10 mg/mL serve as an effective and biosecure substitute for egg yolk in Tris extenders, enhancing motility, viability, and structural integrity of Ongole-grade bull spermatozoa. This locally developed, plant-based nanotechnology supports biosafety, import substitution, and sustainability of artificial insemination programs in Indonesia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.